Trials / Terminated
TerminatedNCT01650298
Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation
Pilot Study: Tailored Anticoagulation for Noncontinuous AF
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether it is safe to stop anticoagulation medication in patients with a history of atrial fibrillation (AF) based on information from a pacemaker or implantable cardioverter defibrillator (ICD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Drug (Direct thrombin or Factor Xa inhibitor) | Patient will stop or restart drug per cardiac device information (AT/AF diagnostics for prespecified AT/AF episode duration per day and total burden). |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2016-12-01
- Completion
- 2017-08-01
- First posted
- 2012-07-26
- Last updated
- 2020-08-13
- Results posted
- 2020-08-13
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01650298. Inclusion in this directory is not an endorsement.